Soluble CD163 (sCD163)—the shed form of the macrophage hemoglobin–haptoglobin scavenger receptor—serves as a sensitive marker of monocyte/macrophage activation, rising with inflammatory burden and tissue injury in conditions such as macrophage activation syndrome/HLH, autoimmune flares, sepsis, and inflammatory liver disease (e.g., alcoholic hepatitis, NASH, cirrhosis). At Southern Medical Supplies Limited (SMSL), we offer serum/ plasma sCD163 testing via ELISA and chemiluminescent immunoassays, with optional reflex panels (e.g., ferritin, sIL-2R, CRP, IL-6) to enhance clinical interpretation and monitoring of treatment response. Our portfolio draws on a broad network of trusted global partners—EUROIMMUN, Ansh Labs, Randox, Streck, Bio-Rad, Abbott, Roche, Siemens Healthineers, Qiagen, bioMérieux, Cepheid, Werfen, Globe Scientific, ELGA LabWater, LW Scientific, Sebia, LTA SRL, Acrobiotech, MAKOL Innovacion Medica, Rayto Life and Analytical Sciences, Diazyme, Hardy’s Diagnostics, and Teco Diagnostics—ensuring analytical sensitivity, specificity, and reproducibility to support confident diagnosis, risk stratification, and longitudinal disease tracking.